FedEx Blog

FedEx Blog

Latest Posts by Christelle Laot

May 2, 2016

Cold Chain Hub Lowers Risk for Healthcare Imports

Avoiding clearance delays is critical for temperature-sensitive pharmaceuticals shipments since they risk being spoiled at the port of clearance if no cold chain infrastructure is available. FedEx Express has been investing in cold chain areas at airports to maintain the integrity of delayed international healthcare air shipments. As a matter of fact, the FedEx Express

March 9, 2016

Developing Shipping Solutions for Pharmerging Markets

Pharmaceutical markets can be divided into three categories: mature markets, pharmerging markets and underdeveloped markets. The term “pharmerging” is a word that combines pharmaceutical industry and emerging markets. It is used by consultants to describe high-growth pharmaceutical markets, which are generally characterized by a double-digit compound annual growth rate. Within the pharmerging category, China alone accounts for

February 17, 2016

C-TPAT Certified? You Bet!

Security is a major concern for pharmaceutical companies, which have a goal to bring safe and effective medicine to patients, but also protect their revenues and brand names. The pharmaceutical supply chain is highly complex, with many components and ingredients being sourced from various countries to the manufacturing plant, and then exported out of the

February 1, 2016

Need to Improve FDA Import Data

Most foreign shippers are aware that specific documentation requirements such as commercial invoice and the use of appropriate Harmonized Tariff Schedule (HTS) codes are required for a commercial shipment to enter the United States from abroad. When an import shipment is regulated by the Food and Drug Administration (FDA), additional data elements can make the

December 28, 2015

An In-depth Look at PREDICT for FDA Import Clearance

Have you ever heard of PREDICT for FDA import clearance? When a shipment regulated by the Food and Drug Administration (FDA) arrives at the US border, there are two options: It can either be released immediately by the federal agency without further examination, or it can experience a delay at the American port of entry.

November 10, 2015

Crossing U.S. Borders: Facilitating the Clearance of Critical Healthcare Shipments

Healthcare supply chains are becoming increasingly global and complex. Biopharma products are often manufactured in one part of the world and sold in another, while clinical trials are conducted in remote populations with limited access to medicine. As a result, healthcare shipments have to cross borders and even continents for package contents to reach final